We are still accepting applications for September 2020 start on our MSc in Model-based Drug Development programme. Our MSc focuses on the modelling and simulation skills that are currently transforming the drug development industry. The course has been developed with an emphasis on mechanistic approaches to assessing and predicting pharmacokinetics and pharmacodynamics (PKPD), such as physiologically-based pharmacokinetics (PBPK). Full-time students benefit from immersion in the varied biomedical research environment at The University of Manchester, including interaction with research staff at the renowned Centre for Applied Pharmacokinetic Research.
We require an UG honours degree (minimum Lower Second or equivalent) from a reputable internationally-recognised institution. You will qualify as a modeller with key skills in computational approaches in pharmacokinetics and pharmacodynamics. Some of our modules include Introduction to Basic Pharmacokinetics and Pharmacodynamics, In-vito-In-vivo extrapolation (IVIVE) in ADME, Physiologically- based Pharmacokinetic Modelling, Advanced topics (including modelling of absorption) in PBPK, Data Analysis in Pharmacokinetics and Pharmacodynamics and Research project. The aim of the course is to provide specialist knowledge and skills that are highly relevant for a career linked to drug development and pharmaceutical industry. On the course you will develop and acquire experience of using different software platforms related to pharmacometric data analysis including R, Phoenix, NONMEM, MATLAB, Simcyp, and MONOLIX. The course emphasises the development of problem-solving skills. A large portion of the learning involves structured problems requiring you to apply theory and practical skills to solve typical problems that arise in drug development. Our distance learning option is ideal for scientists linked to the pharmaceutical industry who wish to expand their expertise while working in the industry. It is also possible to take certain modules/units on the programme as a standalone, CPD type course in 6weeks for 15 credit or 12weeks for 30credits modules/units. For more information please visit our website https://www.manchester.ac.uk/study/masters/courses/list/08749/msc-model-based-drug-development/ Regards Kay Kayode Ogungbenro, PhD Lecturer in Cancer Pharmacometrics | Division of Pharmacy and Optometry | School of Health Sciences The University of Manchester | Manchester M13 9PT | United Kingdom Tel: +441612752399 Email: kayode.ogungbe...@manchester.ac.uk<mailto:kayode.ogungbe...@manchester.ac.uk> Web: https://www.research.manchester.ac.uk/portal/kayode.ogungbenro.html
